One in seven Canadian veterans is living with PTSD. Developing a psychedelics research program for veterans should be a public health priority.
Academic rigor, journalistic flair
Articles on Psychedelic
Displaying all articles
This latest research provides hope for people whose symptoms are harder to treat.
Receiving a cancer diagnosis and undergoing cancer treatment can be a traumatizing experience. Psychedelics like LSD, psilocybin and MDMA could help alleviate symptoms from cancer-related PTSD.
Alberta’s new policy on psychedelic-assisted therapy for mental illness may set a precedent that moves Canadians one step closer to accepting psychedelics as medicinal substances.
A transcript of an episode of The Conversation Weekly published on September 29, 2022.
Society has very different attitudes to near-death experiences and psychedelics.
Psychedelics can help reset the brain, shaking it out of old patterns. The current state of uncertainty could have similar impacts - a metaphorical psychedelic dose - for new insights.
Top contributors
-
Research Scientist, Queen's Health Sciences and Assistant Professor, Department of Psychiatry, Queen's University, Ontario
-
Distinguished Professor of Neurology and Psychiatry, Director of Psychedelics Division at Neuroscape, University of California, San Francisco
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor and Canada Research Chair in the History of Health & Social Justice, University of Saskatchewan
-
Senior Lecturer in Psychology, Leeds Beckett University
-
Emeritus Professor, The National Centre for Youth Substance Use Research, The University of Queensland
-
Associate Science Editor & Co-Host of The Conversation Weekly Podcast, The Conversation
-
Postdoctoral Researcher in Child Psychiatry, Vrije Universiteit Amsterdam
-
Enterprise Fellow (Senior Research Fellow/Senior Lecturer), University of South Australia
-
Editor and Co-Host, The Conversation Weekly Podcast, The Conversation
